Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation

Overview of attention for article published in Breast Cancer Research, May 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 56 Mendeley
citeulike: 1 CiteULike

Summary X Dimensions citations

So far, Dimensions has found 42 publications that cite this research output.

42

The most recent citing publications are shown below. View all 42 publications that cite this research output on Dimensions.

APOBEC Mutagenesis in Cancer Development and Susceptibility

Article in Cancers (January 2024)

Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)

Article in European Journal of Cancer (October 2023)

The APOBEC3B c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population

Article in Genes (June 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.